While the controversy around psychedelics may be associated with certain moral views, there is little controversy when used for scientific purposes. Despite what people may think, one person discusses that they do much more than anchor two major network news shows.
There is overlapping evidence that the use of psychedelic drugs creates wild and unusual experiences, reportedly healing depressed people back to normality. This has encouraged a group of scientists to embark on studies in an attempt to disburse psychedelic drugs on the market for treating depression.
Studies have shown that classic psychedelics like psilocybin, LSD, mescaline, and DMT do not have an addictive signal in all animal models tested, and may even offer some therapeutic benefits for depression.
Studies on psychedelic drugs such as psilocybin and MDMA have been successful in treating depression and other mental illnesses. Researchers at prestigious institutions, such as Johns Hopkins and NYU, have seen a high number of patients in remission from depression after taking the drugs.